Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) 17. March 2022, section EUDA news
13. February 2026 Action on drug precursors: first EU-level precursor assessment reports published Illicit drug production poses a growing threat to public health and security in Europe. Monitoring drug precursor markets...
